• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 52 of 100
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
Health
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
By Hallie DetrickApril 9, 2018
US-ECONOMY-STOCK MARKET
Health
Why Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It
By Sy MukherjeeApril 6, 2018
Flu Vaccine Shortage Continues
Health
Flu Season Is Still Going Strong
By Emily PriceMarch 30, 2018
Neisseria Gonorrhoeae
Health
The U.K. Just Confirmed Its 1st Case of ‘Super Gonorrhea.’ And It’s Freaking Out Health Experts
By Sy MukherjeeMarch 29, 2018
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health
This Company Beat the Odds to Become One of the World’s Most ‘Innovative’ Drug Giants
By Sy MukherjeeMarch 28, 2018
Pharmaceuticals, Viagra
Health
Viagra Just Turned 20. Here’s How Much Money the ED Drug Makes
By Sy MukherjeeMarch 27, 2018
GlaxoSmithKline Is Buying Out Novartis’s Share in Their Consumer Health Joint Venture
Health
GlaxoSmithKline Is Buying Out Novartis’s Share in Their Consumer Health Joint Venture
By David MeyerMarch 27, 2018
Walker For Handicapped Person
Health
Doctors Say They’ve Found a ‘Game Changing’ Stem Cell Treatment for MS
By Hallie DetrickMarch 19, 2018
The Progress We’ve Made Fighting ALS, the Disease Stephen Hawking Suffered From
Health
The Progress We’ve Made Fighting ALS, the Disease Stephen Hawking Suffered From
By Sy MukherjeeMarch 14, 2018
prescription-drugs-teva-pharmaceutical
Health
Why U.S. Health Care Costs Are Twice As High As Other High-Income Countries
By Kirsten KorosecMarch 14, 2018
Dow Jones Average Continues Sharp Decline
Health
Why This Acne Drug Maker’s Stock Is Plummeting Over 60%
By Chris MorrisMarch 5, 2018
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, departs after a hearing at U.S. Federal Court in Brooklyn, New York
Health
Martin Shkreli May Spend 20 Years in Prison
By Chris MorrisFebruary 27, 2018
Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day
Health
Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day
By Sy MukherjeeFebruary 23, 2018
Albertsons To Be Sold For $17.4 Billion
Retail
Albertsons Might Be Buying a Lemon in Rite Aid
By Phil WahbaFebruary 20, 2018
Why Albertsons Is Buying a Big Chunk of Rite Aid
Retail
Why Albertsons Is Buying a Big Chunk of Rite Aid
By Natasha BachFebruary 20, 2018
1...
  • 50
  • 51
  • 52
  • 53
  • 54
...100
Most Popular
Real Estate
The millennial generation has split, new Fed research shows: Those over 35 are edging toward boomer-style wealth, while everyone else falls behindplaceholder alt text
By Nick LichtenbergJuly 22, 2026
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
AI
Mathematicians grapple with a ‘very rapid and very unsettling change’ as AI cracks yet another century-old problemplaceholder alt text
By Eva RoytburgJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.